Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$66.81 - $80.83 $3.26 Million - $3.94 Million
48,800 Added 163.2%
78,702 $6.14 Million
Q1 2024

May 07, 2024

BUY
$61.03 - $69.57 $586,010 - $668,011
9,602 Added 47.3%
29,902 $2.03 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $92,835 - $103,920
1,500 Added 7.98%
20,300 $1.37 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $1.22 Million - $1.35 Million
18,800 New
18,800 $1.27 Million
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $4.28 Million - $5.56 Million
-79,000 Reduced 50.54%
77,300 $5.24 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $3.49 Million - $8.95 Million
65,900 Added 72.9%
156,300 $8.57 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $3.24 Million - $3.89 Million
54,700 Added 153.22%
90,400 $5.97 Million
Q1 2022

May 16, 2022

SELL
$55.72 - $67.12 $8.5 Million - $10.2 Million
-152,576 Reduced 81.04%
35,700 $2.37 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $10.2 Million - $12 Million
188,276 New
188,276 $11 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sal Trading, LLC Portfolio

Follow Sal Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sal Trading, LLC with notifications on news.